This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
fgf23
FGF23
FGF23 is an osteocyte-secreted hormone that reduces renal phosphate reabsorption and inhibits vitamin D activation via FGFR1/αKlotho; elevated 100-1000× in CKD → drives secondary hyperparathyroidism, LVH, and mortality; burosumab (anti-FGF23) treats XLH-related rickets.
Entry Metadata
| Field | Value |
|---|---|
| ID | fgf23 |
| Name | FGF23 |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004;19(3):429-435. · PubMed 15040830
- Gutierrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359(6):584-592. · PubMed 18687639